Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders

Bone Marrow Transplant. 2023 May;58(5):600-602. doi: 10.1038/s41409-023-01937-1. Epub 2023 Feb 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease-Free Survival
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans